Error: Could not add to watchlist. X

ImmunoGen Inc

+ Watchlist
IMGN:US
NASDAQ GS
16.33
USD
0.30
1.80%
As of 17:20:00 ET on 08/04/2015.
Open
16.72
Day Range
16.12 - 16.76
Volume
1,524,776
Previous Close
16.63
52Wk Range
5.34 - 19.43
1 Yr Return
53.77%
Open
16.72
Day Range
16.12 - 16.76
Volume
1,524,776
Previous Close
16.63
52Wk Range
5.34 - 19.43
1 Yr Return
53.77%
YTD Return
167.70%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.70
Market Cap (b USD)
1.398
Shares Outstanding (m)
86.185
Price/Sales (TTM)
16.49
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
ImmunoGen, Inc. develops targeted anticancer therapeutics using its Targeted Antibody Payload (TAP) technology together with its expertise in monoclonal antibodies and tumor biology. A TAP compound uses a tumor-targeting monoclonal antibody to deliver one of ImmunoGen's purpose-developed cancer-killing agents specifically to tumor cells.
ADDRESS
830 Winter Street
Waltham, MA 02451-1477
United States
PHONE
1-781-895-0600
  • Daniel M Junius "Dan"
    President/CEO
  • David B Johnston "Dave"
    Exec VP/CFO/Treasurer
  • Sandra E Poole
    Senior VP:Technical Operations
  • Charles Q Morris "Charlie"
    Exec VP/Chief Development Officer
  • Anna Berkenblit
    VP/Chief Medical Officer
Show More